This Article Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by BOWERS, C. Y. Articles by FAGLIA, G. Search for Related Content PubMed PubMed Citation Articles by BOWERS, C. Y. Articles by FAGLIA, G.

Growth Hormone (GH)-Releasing Peptide Stimulates GH Release in Normal Men and Acts Synergistically with GH-Releasing Hormone^*

Section of Endocrinology and Metabolism, Department of Medicine, Tulane University Medical School (C.Y.B., G.A.R., D.D., C.M.B.) New Orleans, Louisiana 70112
the Division of Endocrinology and Metabolism, Department of Medicine, University of Virginia Health Sciences Center (S.S.P., M.O.T.) Charlottesville, Virginia 22908

Address requests for reprints to: Dr. C. Y. Bowers, Section of Endocrinology and Metabolism, Department of Medicine, Tulane University Medical School, New Orleans, Louisiana 70112.

The acute GH release stimulated by the synthetic hexapeptide, His-DTrp-Ala-Trp-DPhe-Lys-NH₂ [GH releasing peptide (GHRP)], was determined in 18 normal men and compared with the effects of GH-releasing hormone, GHRH-(1–44)-NH₂. Specificity of effect was assessed by measurement of serum PRL, LH, TSH, and cortisol. GHRP was administered at doses of 0.1, 0.3, and 1.0 µg/kg by iv bolus. GHRH at a dose of 1.0 µg/kg was administered alone and together with various does of GHRP.

No adverse clinical effects or laboratory abnormalities were observed in response to GHRP. A side-effect of mild facial flushing of 1- to 3-min duration occurred in 16 of the 18 subjects who received GHRH-(l–44)-NH2. Mean (±SEM) peak serum GH levels after injection ofplacebo and 0.1, 0.3, and 1.0 µg/kg GHRP were 1.2 ± 0.3, 7.6 ± 2.5, 16.5 ± 4.1, and 68.7 ± 15.5 µg/L, respectively. The submaximal dosages of 0.1 and 0.3 µg/kg GHRP plus 1 µg/kg GHRH stimulated GH release synergistically. Serum PRL and cortisol levels rose about 2-fold above basal levels only at the 1 µg/kg dose of GHRP, and there were no changes in serum LH and TSH over the first hour after administration of the peptide(s).

GHRP is a potent secretagogue of GH in normal men. Since GHRP and GHRH together stimulate GH release synergistically, these results suggest that GHRP and GHRH act independently. This supports our hypothesis that the GH-releasing activity of GHRP reflects a new physiological system in need of further characterization in animals and man.

^* This work was supported in part by Grant DK-32632 and GCRC Grant RR-0847. Presented at the 71st Annual Meeting of The Endocrine Society, Seattle, WA, June 1989.

Received August 14, 1989.

This article has been cited by other articles:

				F. F. Casanueva, J. P. Camina, M. C. Carreira, Y. Pazos, J. L. Varga, and A. V. Schally Growth hormone-releasing hormone as an agonist of the ghrelin receptor GHS-R1a PNAS, December 23, 2008; 105(51): 20452 - 20457. [Abstract] [Full Text] [PDF]

				R. D. Kineman and R. M. Luque Evidence that Ghrelin Is as Potent as Growth Hormone (GH)-Releasing Hormone (GHRH) in Releasing GH from Primary Pituitary Cell Cultures of a Nonhuman Primate (Papio anubis), Acting through Intracellular Signaling Pathways Distinct from GHRH Endocrinology, September 1, 2007; 148(9): 4440 - 4449. [Abstract] [Full Text] [PDF]

				J. D. Veldhuis, M. Cosma, D. Erickson, R. Paulo, K. Mielke, L. S. Farhy, and C. Y. Bowers Tripartite Control of Growth Hormone Secretion in Women during Controlled Estradiol Repletion J. Clin. Endocrinol. Metab., June 1, 2007; 92(6): 2336 - 2345. [Abstract] [Full Text] [PDF]

				D. Stevanovic, V. Milosevic, D. Nesic, V. Ajdzanovic, V. Starcevic, and W. B. Severs A BRIEF COMMUNICATION: Central Effects of Ghrelin on Serum Growth Hormone and Morphology of Pituitary Somatotropes in Rats. Experimental Biology and Medicine, November 1, 2006; 231(10): 1610 - 1615. [Abstract] [Full Text] [PDF]

				X. Bonnefont, A. Lacampagne, A. Sanchez-Hormigo, E. Fino, A. Creff, M.-N. Mathieu, S. Smallwood, D. Carmignac, P. Fontanaud, P. Travo, et al. Revealing the large-scale network organization of growth hormone-secreting cells PNAS, November 15, 2005; 102(46): 16880 - 16885. [Abstract] [Full Text] [PDF]

				L. S. Farhy and J. D. Veldhuis Deterministic construct of amplifying actions of ghrelin on pulsatile growth hormone secretion Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2005; 288(6): R1649 - R1663. [Abstract] [Full Text] [PDF]

				P. R. Le Tissier, D. F. Carmignac, S. Lilley, A. K. Sesay, C. J. Phelps, P. Houston, K. Mathers, C. Magoulas, D. Ogden, and I. C. A. F. Robinson Hypothalamic Growth Hormone-Releasing Hormone (GHRH) Deficiency: Targeted Ablation of GHRH Neurons in Mice Using a Viral Ion Channel Transgene Mol. Endocrinol., May 1, 2005; 19(5): 1251 - 1262. [Abstract] [Full Text] [PDF]

				A. M. Avram, C. A. Jaffe, K. V. Symons, and A. L. Barkan Endogenous Circulating Ghrelin Does Not Mediate Growth Hormone Rhythmicity or Response to Fasting J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2982 - 2987. [Abstract] [Full Text] [PDF]

				V. Popovic, D. Miljic, S. Pekic, P. Pesko, M. Djurovic, M. Doknic, S. Damjanovic, D. Micic, G. Cvijovic, J. Glodic, et al. Low Plasma Ghrelin Level in Gastrectomized Patients Is Accompanied by Enhanced Sensitivity to the Ghrelin-Induced Growth Hormone Release J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 2187 - 2191. [Abstract] [Full Text] [PDF]

				A. J. van der Lely, M. Tschop, M. L. Heiman, and E. Ghigo Biological, Physiological, Pathophysiological, and Pharmacological Aspects of Ghrelin Endocr. Rev., June 1, 2004; 25(3): 426 - 457. [Abstract] [Full Text] [PDF]

				S. Lall, N. Balthasar, D. Carmignac, C. Magoulas, A. Sesay, P. Houston, K. Mathers, and I. Robinson Physiological Studies of Transgenic Mice Overexpressing Growth Hormone (GH) Secretagogue Receptor 1A in GH-Releasing Hormone Neurons Endocrinology, April 1, 2004; 145(4): 1602 - 1611. [Abstract] [Full Text] [PDF]

				S. R. Cunha and K. E. Mayo Ghrelin and Growth Hormone (GH) Secretagogues Potentiate GH-Releasing Hormone (GHRH)-Induced Cyclic Adenosine 3',5'-Monophosphate Production in Cells Expressing Transfected GHRH and GH Secretagogue Receptors Endocrinology, December 1, 2002; 143(12): 4570 - 4582. [Abstract] [Full Text] [PDF]

				L. M. Frago, C. Paneda, S. L. Dickson, A. K. Hewson, J. Argente, and J. A. Chowen Growth Hormone (GH) and GH-Releasing Peptide-6 Increase Brain Insulin-Like Growth Factor-I Expression and Activate Intracellular Signaling Pathways Involved in Neuroprotection Endocrinology, October 1, 2002; 143(10): 4113 - 4122. [Abstract] [Full Text] [PDF]

				M. Imazio, M. Bobbio, F. Broglio, A. Benso, V. Podio, M.R. Valetto, G. Bisi, E. Ghigo, and G.P. Trevi GH-independent cardiotropic activities of hexarelin in patients with severe left ventricular dysfunction due to dilated and ischemic cardiomyopathy Eur J Heart Fail, March 1, 2002; 4(2): 185 - 191. [Abstract] [Full Text] [PDF]

				S. M. Anderson, L. Wideman, J. T. Patrie, A. Weltman, C. Y. Bowers, and J. D. Veldhuis E2 Supplementation Selectively Relieves GH's Autonegative Feedback on GH-Releasing Peptide-2-Stimulated GH Secretion J. Clin. Endocrinol. Metab., December 1, 2001; 86(12): 5904 - 5911. [Abstract] [Full Text] [PDF]

				F. Roelfsema, N. R. Biermasz, R. G. Veldman, J. D. Veldhuis, M. Frolich, W. H. Stokvis-Brantsma, and J.-M. Wit Growth Hormone (GH) Secretion in Patients with an Inactivating Defect of the GH-Releasing Hormone (GHRH) Receptor Is Pulsatile: Evidence for a Role for Non-GHRH Inputs into the Generation of GH Pulses J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2459 - 2464. [Abstract] [Full Text] [PDF]

				M. G. Murphy, S. Weiss, M. McClung, T. Schnitzer, K. Cerchio, J. Connor, D. Krupa, and B. J. Gertz Effect of Alendronate and MK-677 (a Growth Hormone Secretagogue), Individually and in Combination, on Markers of Bone Turnover and Bone Mineral Density in Postmenopausal Osteoporotic Women J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1116 - 1125. [Abstract] [Full Text]

				N. Shah, W. S. Evans, C. Y. Bowers, and J. D. Veldhuis Oral Estradiol Administration Modulates Continuous Intravenous Growth Hormone (GH)-Releasing Peptide-2-Driven GH Secretion in Postmenopausal Women J. Clin. Endocrinol. Metab., August 1, 2000; 85(8): 2649 - 2659. [Abstract] [Full Text]

				T. MAHAJAN and S. L. LIGHTMAN A Simple Test for Growth Hormone Deficiency in Adults J. Clin. Endocrinol. Metab., April 1, 2000; 85(4): 1473 - 1476. [Abstract] [Full Text]

				A.-C. A. R. Pinto, M. R. D. Silva, M. R. Martins, E. Brunner, and A.-M. J. Lengyel Effects of Short-Term Glucocorticoid Deprivation on Growth Hormone (GH) Response to GH-Releasing Peptide-6: Studies in Normal Men and in Patients with Adrenal Insufficiency J. Clin. Endocrinol. Metab., April 1, 2000; 85(4): 1540 - 1544. [Abstract] [Full Text]

				M. Roumi, S. Marleau, P. du Souich, T. Maggi, R. Deghenghi, and H. Ong Kinetics and Disposition of Hexarelin, A Peptidic Growth Hormone Secretagogue, in Rats Drug Metab. Dispos., January 1, 2000; 28(1): 44 - 50. [Abstract] [Full Text]

				O. C. Palyha, S. D. Feighner, C. P. Tan, K. K. McKee, D. L. Hreniuk, Y.-D. Gao, K. D. Schleim, L. Yang, G. J. Morriello, R. Nargund, et al. Ligand Activation Domain of Human Orphan Growth Hormone (GH) Secretagogue Receptor (GHS-R) Conserved from Pufferfish to Humans Mol. Endocrinol., January 1, 2000; 14(1): 160 - 169. [Abstract] [Full Text]

				M. Gasperi, G. Aimaretti, G. Scarcello, G. Corneli, C. Cosci, E. Arvat, E. Martino, and E. Ghigo Low Dose Hexarelin and Growth Hormone (GH)-Releasing Hormone as a Diagnostic Tool for the Diagnosis of GH Deficiency in Adults: Comparison with Insulin-Induced Hypoglycemia Test J. Clin. Endocrinol. Metab., August 1, 1999; 84(8): 2633 - 2637. [Abstract] [Full Text]

				M. Korbonits, G. Kaltsas, L. A. Perry, P. Putignano, A. B. Grossman, G. M. Besser, and P. J. Trainer The Growth Hormone Secretagogue Hexarelin Stimulates the Hypothalamo-Pituitary-Adrenal Axis via Arginine Vasopressin J. Clin. Endocrinol. Metab., July 1, 1999; 84(7): 2489 - 2495. [Abstract] [Full Text]

				N. Shah, W. S. Evans, C. Y. Bowers, and J. D. Veldhuis Tripartite Neuroendocrine Activation of the Human Growth Hormone (GH) Axis in Women by Continuous 24-Hour GH-Releasing Peptide Infusion: Pulsatile, Entropic, and Nyctohemeral Mechanisms J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 2140 - 2150. [Abstract] [Full Text]

				K.-D. Schleim, T. Jacks, P. Cunningham, W. Feeney, E. G. Frazier, G. W. Niebauer, D. Zhang, H. Chen, R. G. Smith, and G. Hickey Increases in Circulating Insulin-Like Growth Factor I Levels by the Oral Growth Hormone Secretagogue MK-0677 in the Beagle Are Dependent upon Pituitary Mediation Endocrinology, April 1, 1999; 140(4): 1552 - 1558. [Abstract] [Full Text]

				E. E. Muller, V. Locatelli, and D. Cocchi Neuroendocrine Control of Growth Hormone Secretion Physiol Rev, April 1, 1999; 79(2): 511 - 607. [Abstract] [Full Text] [PDF]

				H. G. Maheshwari, A. Rahim, S. M. Shalet, and G. Baumann Selective Lack of Growth Hormone (GH) Response to the GH-Releasing Peptide Hexarelin in Patients with GH-Releasing Hormone Receptor Deficiency J. Clin. Endocrinol. Metab., March 1, 1999; 84(3): 956 - 959. [Abstract] [Full Text]

				A. Giustina and J. D. Veldhuis Pathophysiology of the Neuroregulation of Growth Hormone Secretion in Experimental Animals and the Human Endocr. Rev., December 1, 1998; 19(6): 717 - 797. [Abstract] [Full Text]

				H. G. Maheshwari, B. L. Silverman, J. Dupuis, and G. Baumann Phenotype and Genetic Analysis of a Syndrome Caused by an Inactivating Mutation in the Growth Hormone-Releasing Hormone Receptor: Dwarfism of Sindh J. Clin. Endocrinol. Metab., November 1, 1998; 83(11): 4065 - 4074. [Abstract] [Full Text]

				K. Hanew, A. Utsumi, A. Tanaka, H. Ikeda, and Y. Yokogoshi Secretory Mechanisms of Growth Hormone (GH)-Releasing Peptide-, GH-Releasing Hormone-, and Thyrotropin-Releasing Hormone-Induced GH Release in Patients with Acromegaly J. Clin. Endocrinol. Metab., October 1, 1998; 83(10): 3578 - 3583. [Abstract] [Full Text]

				D. F. Carmignac, P. A. Bennett, and I. C. A. F. Robinson Effects of Growth Hormone Secretagogues on Prolactin Release in Anesthetized Dwarf (dw/dw) Rats Endocrinology, August 1, 1998; 139(8): 3590 - 3596. [Abstract] [Full Text] [PDF]

				V. Mericq, F. Cassorla, T. Salazar, A. Avila, G. Iñiguez, C. Y. Bowers, and G. R. Merriam Effects of Eight Months Treatment with Graded Doses of a Growth Hormone (GH)-Releasing Peptide in GH-Deficient Children J. Clin. Endocrinol. Metab., July 1, 1998; 83(7): 2355 - 2360. [Abstract] [Full Text]

				D. Micic, V. Popovic, M. Doknic, D. Macut, C. Dieguez, and F. F. Casanueva Preserved Growth Hormone (GH) Secretion in Aged and Very Old Subjects after Testing with the Combined Stimulus GH-Releasing Hormone plus GH-Releasing Hexapeptide-6 J. Clin. Endocrinol. Metab., July 1, 1998; 83(7): 2569 - 2572. [Abstract] [Full Text]

				I. Shimon and S. Melmed Human Fetal Pituitary Expresses Functional GHRP Receptors--Authors' Responsee J. Clin. Endocrinol. Metab., June 1, 1998; 83(6): 2216a - 2217. [Full Text]

				R. Moreno-Reyes, M. Kerkhofs, M. L'Hermite-Baleriaux, M. O. Thorner, E. Van Cauter, and G. Copinschi Evidence against a role for the growth hormone-releasing peptide axis in human slow-wave sleep regulation Am J Physiol Endocrinol Metab, May 1, 1998; 274(5): E779 - E784. [Abstract] [Full Text] [PDF]

				N. Pandya, R. DeMott-Friberg, C. Y. Bowers, A. L. Barkan, and C. A. Jaffe Growth Hormone (GH)-Releasing Peptide-6 Requires Endogenous Hypothalamic GH-Releasing Hormone for Maximal GH Stimulation J. Clin. Endocrinol. Metab., April 1, 1998; 83(4): 1186 - 1189. [Abstract] [Full Text]

				M. G. Murphy, L. M. Plunkett, B. J. Gertz, W. He, J. Wittreich, W. M. Polvino, and D. R. Clemmons MK-677, an Orally Active Growth Hormone Secretagogue, Reverses Diet-Induced Catabolism J. Clin. Endocrinol. Metab., February 1, 1998; 83(2): 320 - 325. [Abstract] [Full Text]

				J. Svensson, L. Lönn, J.-O. Jansson, G. Murphy, D. Wyss, D. Krupa, K. Cerchio, W. Polvino, B. Gertz, I. Boseaus, et al. Two-Month Treatment of Obese Subjects with the Oral Growth Hormone (GH) Secretagogue MK-677 Increases GH Secretion, Fat-Free Mass, and Energy Expenditure J. Clin. Endocrinol. Metab., February 1, 1998; 83(2): 362 - 369. [Abstract] [Full Text]

				I. Shimon, X. Yan, and S. Melmed Human Fetal Pituitary Expresses Functional Growth Hormone-Releasing Peptide Receptors J. Clin. Endocrinol. Metab., January 1, 1998; 83(1): 174 - 178. [Abstract] [Full Text]

				R. G. Smith, L. H. T. Van der Ploeg, A. D. Howard, S. D. Feighner, K. Cheng, G. J. Hickey, M. J. Wyvratt Jr., M. H. Fisher, R. P. Nargund, and A. A. Patchett Peptidomimetic Regulation of Growth Hormone Secretion Endocr. Rev., October 1, 1997; 18(5): 621 - 645. [Abstract] [Full Text]

				I. M. Chapman, O. H. Pescovitz, G. Murphy, T. Treep, K. A. Cerchio, D. Krupa, B. Gertz, W. J. Polvino, E. H. Skiles, S. S. Pezzoli, et al. Oral Administration of Growth Hormone (GH) Releasing Peptide-Mimetic MK-677 Stimulates the GH/Insulin-Like Growth Factor-I Axis in Selected GH-Deficient Adults J. Clin. Endocrinol. Metab., October 1, 1997; 82(10): 3455 - 3463. [Abstract] [Full Text] [PDF]

				R. G. Clark, G. B. Thomas, D. L. Mortensen, W. B. Won, Y. H. Ma, E. E. Tomlinson, K. M. Fairhall, and I. C. A. F. Robinson Growth Hormone Secretagogues Stimulate the Hypothalamic-Pituitary-Adrenal Axis and Are Diabetogenic in the Zucker Diabetic Fatty Rat Endocrinology, October 1, 1997; 138(10): 4316 - 4323. [Abstract] [Full Text] [PDF]

				A. Leal-Cerro, L. M. Jimenez, R. Astorga, I. Fernandez-Lopez, C. Dieguez, and F. F. Casanueva Acute Pharmacological Reduction of Plasma Free Fatty Acids Enhances the Growth Hormone (GH)-Releasing Hormone-Mediated GH Secretion in Patients with Cushing's Syndrome J. Clin. Endocrinol. Metab., September 1, 1997; 82(9): 3165 - 3168. [Abstract] [Full Text] [PDF]

				E. Ghigo, E. Arvat, J. Ramunni, A. Colao, L. Gianotti, R. Deghenghi, G. Lombardi, and F. Camanni Adrenocorticotropin- and Cortisol-Releasing Effect of Hexarelin, a Synthetic Growth Hormone-Releasing Peptide, in Normal Subjects and Patients with Cushing's Syndrome J. Clin. Endocrinol. Metab., August 1, 1997; 82(8): 2439 - 2444. [Abstract] [Full Text] [PDF]

				A. A. Toogood, R. M. Nass, S. S. Pezzoli, P. A. O'Neill, M. O. Thorner, and S. M. Shalet Preservation of Growth Hormone Pulsatility Despite Pituitary Pathology, Surgery, and Irradiation J. Clin. Endocrinol. Metab., July 1, 1997; 82(7): 2215 - 2221. [Abstract] [Full Text] [PDF]

				K. K. McKee, O. C. Palyha, S. D. Feighner, D. L. Hreniuk, C. P. Tan, M. S. Phillips, R. G. Smith, L. H. T. Van der Ploeg, and A. D. Howard Molecular Analysis of Rat Pituitary and Hypothalamic Growth Hormone Secretagogue Receptors Mol. Endocrinol., April 1, 1997; 11(4): 415 - 423. [Abstract] [Full Text]

				S. E. Kirk, B. J. Gertz, S. H. Schneider, M. L. Hartman, S. S. Pezzoli, J. M. Wittreich, D. A. Krupa, J. R. Seibold, and M. O. Thorner Effect of Obesity and Feeding on the Growth Hormone (GH) Response to the GH Secretagogue L-692,429 in Young Men J. Clin. Endocrinol. Metab., April 1, 1997; 82(4): 1154 - 1159. [Abstract] [Full Text] [PDF]

				G. B. Thomas, K. M. Fairhall, and I. C. A. F. Robinson Activation of the Hypothalamo-Pituitary-Adrenal Axis by the Growth Hormone (GH) Secretagogue, GH-Releasing Peptide-6, in Rats Endocrinology, April 1, 1997; 138(4): 1585 - 1591. [Abstract] [Full Text] [PDF]

				S. Loche, A. Colao, M. Cappa, J. Bellone, G. Aimaretti, G. Farello, A. Faedda, G. Lombardi, R. Deghenghi, and E. Ghigo The Growth Hormone Response to Hexarelin in Children: Reproducibility and Effect of Sex Steroids J. Clin. Endocrinol. Metab., March 1, 1997; 82(3): 861 - 864. [Abstract] [Full Text] [PDF]

				G. Van den Berghe, F. de Zegher, J. D. Veldhuis, P. Wouters, M. Awouters, W. Verbruggen, M. Schetz, C. Verwaest, P. Lauwers, R. Bouillon, et al. The Somatotropic Axis in Critical Illness: Effect of Continuous Growth Hormone (GH)-Releasing Hormone and GH-Releasing Peptide-2 Infusion J. Clin. Endocrinol. Metab., February 1, 1997; 82(2): 590 - 599. [Abstract] [Full Text] [PDF]

				R. Smith, K Cheng, W. Schoen, S. Pong, G Hickey, T Jacks, B Butler, W. Chan, L. Chaung, F Judith, et al. A nonpeptidyl growth hormone secretagogue Science, June 11, 1993; 260(5114): 1640 - 1643. [Abstract] [PDF]